About Innate Killer

Improving Patient Care by Advancing Innate Understanding & Enhancing Innate Cell Therapies


What Brings us Together?

The Community wants to improve patient care by providing effective, safe and appropriate treatment. We believe that our best chance at it is to enhance innate therapeutics through research and collaboration, and this is exactly what the Innate Killer Summit wants to help you achieve. Our team is dedicated to supporting the field’s efforts to better connect, research and discover, together.


How do we Help Improve Patient Care?

Thousands of researchers worldwide are trying to advance the understanding and development of innate cell therapies. We bring those leading researchers together annually to discuss how to overcome the common challenges of innate cell therapies and assess the field’s constantly evolving challenges.  The community share common concerns and hopes including:

  • Contemplating the future of off-the-shelf gene edited iPSC derived cell therapies;
  • Discussing how to increase persistence;
  • Exploring novel manufacturing and expansion techniques;
  • Improving the fundamental understanding of NK cells;
  • Advancing innate cell therapy development

By advancing the distribution of ground-breaking innate research, Innate Killer is at the spearhead of improving patient care and supporting innate scientists in their ground-breaking research.


What is the Innate Killer Summit?

The Innate Killer Summit is the oldest and largest industry-focused innate immunity meeting concentrated on all aspects of innate therapeutic development. Our reputation for a unique combination of leading academics alongside industry trailblazers is unparalleled. Our meeting cultivates innovative collaborations and forward-thinking discussions amongst scientists all committed to advancing innate cell therapies.

Join us today and become part of a community with one goal: Improving Patient Care by Advancing Innate Understanding & Enhancing Innate Cell Therapies


The Innate Killer Summit in 2020 

After the CAR-T revolution, investment into other cell types such as NK, gdT and NKT cells has exploded. The Innate Killer Summit 2020 discusses safer, more cost-effective and potentially more efficacious innate cell immunotherapy as the next generation of front line cancer therapy. 

The Innate Killer Summit will help you optimize your manufacturing and process development strategies to further reduce the cost of off-the-shelf NK cell therapies. Discuss the most up to date clinical data on genetically engineered NK cellsgdT, NKT and bispecific engagers to ensure persistence and durability. 

Bringing together over 200 of the field’s leading minds, this meeting allows the community to share experience and knowledge on the optimal NK cell source to further improve the efficacy of NK cell therapies through enhanced targeting methods? Join us at the 5th Annual Innate Killer Summit to bring the next generation of safer and cheaper cell immunotherapies to patients. 


The Innate Killer Summit is the leading, dedicated end-to-end meeting accelerating genetically engineered, off-the-shelf and cost-effective innate cell immunotherapies for solid tumor indications to market.